A week on from increases in the cost of Eli Lilly’s weight loss drug Mounjaro (tirzepatide), weight loss medication provider ...

Uagnda's Dei BioPharma Ltd has announced that the U.S. Food and Drug Administration has accepted the development plan for two of its novel biological drugs, liraglutide and semaglutide, which are used ...

GLP-1s aren't FDA-approved to treat rheumatoid arthritis, but many people notice improvement in their inflammation with the ...